Catalog of Interviews and Bits

Kelly Riddell Sadler, is the Communications Director at America First Action, and a former Special Assistant to President Donald J. Trump.

Terry Giles, author of The Fifteen Percent: Overcoming Hardships and Achieving Lasting Success.

he's the multi-talented author, Ron Singerton - call him at 951-849-3870

he's been winning all sorts of rave reviews for his current best-seller,

"A Cherry Blossom in Winter"--it was given the Goethe First Place Award

for historical fiction in 2017 by the Chanticleer book review company

first, Ron, tell us about the books you wrote before "Cherry Blossom"--you scored

quite a bit of success and the books helped pave the way for a fabulous career

in the world of literature

also, fill us in on your colorful background--where were you reared, the schools

you attended and what really sparked your careers...also your work as an artist,

with artwork in glass, stone, paint and bronze sold and displayed online, in galleries

and numerous art shows--wow!

if you don't mind, read the two paragraphs that entice us on the back cover of

"A Cherry Blossom in Winter"

how different are you from other historical novelists? are most of your books

mostly fiction, meaning the characters and settings (locales)--what's real?

with this book you really fascinated readers with the turn of the 20th century history

dealing with the opulence for the elite, militarism, anti-Semitism, expansion and the trans-Siberian

railway--wowee!

why did you pick the setting of the Japanese/Russian war (1905-06) as the real background for

this book?...so many of us still have a lot to learn about that conflict and its aftermath--an interesting

study of Russian and Japanese navies, battleships and admirals, among other fascinating highlights

of course, we'd like to know about the sequel, "A Blossom in the Ashes," which takes place in the

Pacific, leading to World War II and Japan's participation in that war...when will this novel hit the market?

And how long did it take you to write this one?

what about a movie for any of your books and are there any visual possibilities in the works?

where can our listeners buy your books?

and what is your website?

it's been quite interesting having you as a guest and we wish you further success...we must

have you back soon to hear more of your extraordinary career...best wishes always from all

of us at KJAG Radio

OPENING DAY – CES SHOW

Andrea Smith LIVE FROM THE CES SHOW FLOOR

Join Andrea on opening day at CES 2020 for a look at what’s buzzing at this year’s show. Microsoft is back at this year’s show showing us how the latest laptops, tablets and mobile devices are able to keep us connected. Andrea will show an array of computers explaining their latest capabilities and some of the new innovations you didn’t know about.

SUGGESTED QUESTIONS:

What’s the latest innovation with laptops?

What should we look for when buying a new one?

Where can we go for more info?

Andrea Smith: Andrea Smith, contributor to NBC.com, is an award-winning news and technology journalist. She spent over two decades as technology producer at ABC News and was Lifestyle Channel Editor at Mashable. She has appeared as a guest expert in technology segments on ABC’s World News Now, Good Morning America Now, and ABC affiliated Radio and TV stations across the U.S. and continues to lend her tech expertise in segments for WABC-TV and CNBC. Andrea also enjoys mentoring young women starting out in the business world and is a recipient of the 2015 Women in CE Legacy Award.

FDA approves treatment for leading cause of vision loss…

Is there a time between 7:00am – 12:30pm ET on November 18th that works for you here?

BREAKING MEDICAL NEWS -- INTERVIEW OPPORTUNITY

FOR MONDAY, NOVEMBER 18, 2019

FDA APPROVES NEW TREATMENT FOR WET AMD, A LEADING CAUSE OF VISION LOSS

It's estimated by next year, 1.5 to 1.75 million people in the US will be living with WET AGE-RELATED MACULAR DEGENERATION (wet AMD). It's a leading cause of vision loss and a rapidly growing public health concern.[1-3]

It can start with your vision becoming distorted. It’s harder to see objects clearly.[4] If allowed to progress, it could lead to complete loss of central vision, leaving you unable to read, drive or even recognize familiar faces.[5]

Novartis has just received FDA approval of a new treatment that has the potential to help people affected by wet AMD maintain their vision.

Dr. Peter Kaiser, Director of the Cole Center for Ocular Research and Evaluation and Professor of Ophthalmology at the Cleveland Clinic, knows what patients and their families go through with this disease. He is available to answer your questions and to discuss:

How wet AMD robs people of precious sight and impacts millions of lives

Ways to detect wet AMD

New treatment option for wet AMD

Resources to help people cope with this condition

Challenges of caring for someone with AMD

When you book, we will provide you with supplemental b-roll, guest bio & suggested questions.

Interview courtesy of Novartis Pharmaceuticals Corporation.

INDICATIONS AND USAGE

BEOVU® (brolucizumab-dbll) injection is indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD).

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

BEOVU is contraindicated in patients with ocular or periocular infections, active intraocular inflammation or known hypersensitivity to brolucizumab or any of the excipients in BEOVU. Hypersensitivity reactions may manifest as rash, pruritus, urticaria, erythema, or severe intraocular inflammation.

Please see additional Important Safety Information below and the full Prescribing Information.

WARNINGS AND PRECAUTIONS

Endophthalmitis and Retinal Detachments

Intravitreal injections, including those with BEOVU, have been associated with endophthalmitis and retinal detachments. Proper aseptic injection techniques must always be used when administering BEOVU. Patients should be instructed to report any symptoms suggestive of endophthalmit